MAPT and Alzheimer disease: ERKs, JNKs and P38 MAPK comprise a group of MAPK serine-threonine kinases49, 50; the activation of these kinases has been demonstrated to contribute to tau hyperphosphorylation, which, in turn, participates in AD pathophysiological alterations51.